Clinical Trial

A Phase III Clinical Study to Compare the Safety and Efficacy of 177Lu-DOTATATE Injection and Long-acting Oxytrexine in Adult Patients With NETs

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The study is to evaluate the sstr antagonists, 68Ga-DOTATATE and 177Lu-DOTATATE,as a pair of diagnostic/therapeuticradiopharmaceuticals(theranostics)in patients with NETS
Trial Details
NCT Number NCT07057622
Lead Sponsor HTA Co., Ltd.
Conditions NETS Ga68 Lu177
Enrollment 184 participants
Start Date 2023-12-12
Primary Completion 2026-11-24 (estimated)
Study Completion 2027-02-24 (estimated)
Updated on ClinicalTrials.gov 2025-07-10